Is increased adhesion molecule expression in serosal fibroblasts isolated from patients with inflammatory bowel disease secondary to inflammation?
Patients with inflammatory bowel disease display enhanced ICAM-1 expression in serosal fibroblasts but not dermal fibroblasts, indicating a secondary response to inflammation.
This study suggested that the circulating miR-223 could serve as a potential new biomarker for the detection of schistosome infection and the assessment of the response to chemotherapy.